SCHEMBL23770433

SCHEMBL23770433

Cc1ccccc1-c1nc(NSc2cccc(N3CCCC3)n2)ccc1C(F)(F)F

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PDE10A Q9Y233 3/20 0.36
NPY5R Q15761 1/20 0.35
KDM4E B2RXH2 4/20 0.34
CYP1A2 P05177 3/20 0.34
TDP1 Q9NUW8 2/20 0.34
CYP2C19 P33261 2/20 0.34
ALDH1A1 P00352 1/20 0.34
CYP3A4 P08684 1/20 0.34
CYP2D6 P10635 1/20 0.34
TSHR P16473 1/20 0.34
HSD17B10 Q99714 1/20 0.34
CNR2 P34972 2/20 0.33
TACR1 P25103 2/20 0.33
CYP2C9 P11712 1/20 0.32
GAA P10253 3/20 0.32
L3MBTL1 Q9Y468 2/20 0.32
GBA1 P04062 1/20 0.32
GALR2 O43603 2/20 0.31
GALR1 P47211 2/20 0.31
SIGMAR1 Q99720 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23770664 0.99 NPY5R (0.36) PDE10ANPY5RKDM4ECYP1A2TDP1
SCHEMBL23770859 0.92 CYP1A2 (0.44) KDM4ECYP1A2TDP1CYP2C19ALDH1A1
SCHEMBL23770653 0.92 CNR2 (0.40) CYP1A2CYP2C19ALDH1A1CYP3A4CYP2D6
SCHEMBL23770663 0.92 CYP1A2 (0.43) KDM4ECYP1A2TDP1CYP2C19ALDH1A1
SCHEMBL23770840 0.91 KDM4E (0.35) KDM4ECYP1A2TDP1CYP2C19ALDH1A1
SCHEMBL23770725 0.90 CYP1A2 (0.37) KDM4ECYP1A2TDP1CYP2C19ALDH1A1
SCHEMBL23770592 0.89 ADORA2A (0.32)
SCHEMBL23770647 0.89 KDM4E (0.33) PDE10AKDM4ECYP1A2TDP1CYP2C19
SCHEMBL23770452 0.88 PDE10A (0.34) PDE10ANPY5RKDM4ETDP1CNR2
SCHEMBL23770694 0.88 GALR2 (0.40) PDE10ANPY5RKDM4ECYP1A2TDP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3504194-B1 N-(PYRIDIN-2-YL)PYRIDINE-SULFONAMIDE DERIVATIVES AND THEIR USE IN THE TREATMENT OF DISEASE NOVARTIS AG (CH) 2021-08-18 EP disclosed